Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
Eliano Pio NavareseLara FredianiDavid E KandzariGianluca CaiazzoAngela Marella CennameBernardo CorteseTommaso PivaAndi MuçajCarlo TumscitzFrancesco PaparoniClaudio LarosaTeodoro BiscegliaMila MenozziPaul A GurbelJacek KubicaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
The findings of this proof-of-concept study suggest that as compared to use of conventional agents alone, IC epinephrine provides substantial improvement of coronary flow in STEMI patients with refractory no-reflow during PPCI that may result into improved prognosis.